Kim-Mitsuyama, Shokei
Soejima, Hirofumi
Yasuda, Osamu
Node, Koichi
Jinnouchi, Hideaki
Yamamoto, Eiichiro
Sekigami, Taiji
Ogawa, Hisao
Matsui, Kunihiko
Article History
Received: 29 June 2018
Revised: 5 November 2018
Accepted: 25 November 2018
First Online: 21 January 2019
Compliance with ethical standards
:
: Shokei Kim-Mitsuyama has received consultancy fees/honoraria/research grants from Astellas, Daiichi-Sankyo, and Takeda. Osamu Yasuda has received consultancy fees/honoraria/research grants from Otsuka Pharmaceutical Co., Ltd. and Sanwa Kagaku Kenkyusho Co., Ltd. Koichi Node has received consultancy fees/honoraria/research grants from Boehringer Ingelheim. Hideaki Jinnouchi has received consultancy fees/honoraria/research grants from AstraZeneca Pharmaceuticals, Astellas Pharma, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Takeda, Novartis Pharmaceuticals, Novo Nordisk, and Sanofi. Kunihiko Matsui has received consultancy fees/honoraria/research grants from Daiichi Sankyo and Boehringer Ingelheim Japan. All other authors declare that they have no conflict of interest.